Immunization, Vaccines and Biologicals

Disease-specific areas of work

Development of research standards and guidelines

As the number of donors and technical actors supporting the development of vaccines increases, so does the demand for an independent evaluation of needs, an assessment of priorities, and coordination of efforts to optimize efficiency and alignment of activities. In this context, IVR identifies research gaps of particular relevance to low- and middle-income countries; establishes technical agendas to address these gaps; stimulates the implementation of the technical agendas; and synergizes its portfolio of activities with those of its partners.

Identification of vaccine research priorities

IVR develops and supports standards and guidelines for research into vaccines and vaccination. These activities inform the establishment of new regulatory standards developed by the WHO Quality, Safety and Standards unit, harmonized methods, and tools that permit a comparison of research results. This is particularly relevant for new vaccine candidates as their mechanisms of action are often more complex than those of existing vaccines, and they target diseases with multiple clinical manifestations. In addition, IVR develops good practice guidelines for the appropriate and ethical conduct of research in developing countries, thereby encouraging public confidence and participation in research.

Strengthening research and product development capacity

An increasing number of countries are interested in establishing the technology base to develop and produce vaccines of assured quality. To meet these needs, IVR helps strengthen vaccine R&D capacity in low- and middle-income countries as an integral part of its projects. Examples of this are the provision of guidance on good clinical practice and support to the development of technology hubs and research networks. Moreover, in collaboration with the WHO Department on Public Health, Innovation, and Intellectual Property, IVR facilitates technology transfer to vaccine manufacturers for product development.

Meetings, workshops and events

Action against meningitis

Technical task force on meningitis

The Technical Taskforce for the development of a "roadmap to defeat meningitis by 2030" has held its first meeting in July 2018.

A group of African girls laughing

DEFEATING MENINGITIS BY 2030: baseline situation analysis

The baseline situation analysis (BSA) is intended to inform the development of the global roadmap Defeating meningitis by 2030 and to provide a sound basis to inform its key priorities.

Contact us

Initiative for Vaccine Research
Immunization, Vaccines and Biologicals
World Health Organization (WHO)
20 Avenue Appia
1211 Geneva 27
Fax: +41 (22) 791 48 60

For information on vaccination requirements for international travellers, please visit the WHO international travelers pages